INTERFERENCE OF ZINC SULPHATE WITH TRAMADOL AND DIAZEPAM IMMUNOASSAY TESTING

Authors

  • Mohamed Gaber Ahmed Toxicologist at Forensic Medicine Authority, Cairo, Egypt
  • Sayed El-Sherify Professor Dr. at faculty of science, Menoufia University, Cairo, Egypt

DOI:

https://doi.org/10.29121/granthaalayah.v6.i9.2018.1237

Keywords:

Adulteration, Zinc Sulphate, Tramadol, Diazepam

Abstract [English]

Drug abuse is a significant public health issue in many countries worldwide. Tramadol used to help relieving moderate to moderately severe pain. Tramadol works similar to opioid (narcotic) analgesics in their mechanism of action. Diazepam belongs to a class of drugs known as benzodiazepines. Diazepam used to treat medical conditions such as alcohol withdrawal, anxiety and seizures. It could be used to relieve muscle spasm and to provide sedation before medical procedures. Immunoassay tests are commonly used health care field. Depending on those circumstances; this study investigated the potential interference of zinc ion used as a direct adulterant for enzyme multiplied immunoassay technique (EMIT)-based drugs of abuse testing in urine samples. For confirmatory testing, Ultra Performance Liquid Chromatography with photodiode array detector method was utilized. The effect of zinc sulfate existence on two drugs of abuse, tramadol and diazepam, was explored and a minimum concentration of 10 mg/ml was found to be effective for adulteration purpose

Downloads

Download data is not yet available.

References

Moeller, KE., Lee, KC., Kissack, JC. Urine Drug Screening. Mayo Clinic Proceedings, 83, 2008, 66-76. DOI: https://doi.org/10.4065/83.1.66

Feldkamp, CS. Immunological Reactions, In: Clinical Chemistry, Theory, Analysis, and Correlation, St. Louis, 2010.

Chou, R., Fanciullo, G., Fine, P., Adler and J., Davies, J. Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain. The Journal of Pain 10, (2), 2009, 113-130.

Atluri, S., Sudarshan, G. Evaluation of Abnormal Urine Drug Screens among Patients with Chronic Non-Malignant Pain Treated with Opioids. Pain Physician, 6, (4), 2003, 407-409.

Ives, T., Chelminski, P., Hammett-Stabler, C., Malone, R., et al. Predictors of Opioid Misuse in Patients with Chronic Pain: A Prospective Cohort Study. BMC Health Services, 2006. Res. 6: 46. https://www.ncbi.nlm.nih.gov DOI: https://doi.org/10.1186/1472-6963-6-46

Madras, B., Compton, W., Avula, D., Stegbauer, T., Stein, J., Clark, H. Screening, Brief Interventions, Referral to Treatment (Sbirt) for Illicit Drug and Alcohol Use at Multiple Healthcare Sites: Comparison at Intake and 6 Months Later. Drug and Alcohol Dependence. 99, 2009, 280-295. DOI: https://doi.org/10.1016/j.drugalcdep.2008.08.003

Medical Review Officer Manual for Federal Agency Workplace Drug Testing Programs, 2010.

https://www.samhsa.gov

Guideline on bioanalytical method validation. EMEA/CHMP/EWP, 2011.

http://www.ema.europa.eu

Venkatratnam, A., Nathan, HL. Zinc Reduces the Detection of Cocaine, Methamphetamine, and THC by ELISA Urine Testing, Journal of Analytical Toxicology, 35, 2011, 333-340. DOI: https://doi.org/10.1093/anatox/35.6.333

Centers for Disease Control and Prevention. Adult blood lead epidemiology and surveillance—United States. Morbidity and Mortality Weekly Report, 58, 2009, 365-369.

Downloads

Published

2018-09-30

How to Cite

Ahmed, M. G., & El-Sherify, S. (2018). INTERFERENCE OF ZINC SULPHATE WITH TRAMADOL AND DIAZEPAM IMMUNOASSAY TESTING. International Journal of Research -GRANTHAALAYAH, 6(9), 326–331. https://doi.org/10.29121/granthaalayah.v6.i9.2018.1237